FMP

FMP

Enter

IDXG - Interpace Bioscience...

photo-url-https://images.financialmodelingprep.com/symbol/IDXG.png

Interpace Biosciences, Inc.

IDXG

PNK

Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; PanDNA, a molecular only version of PancraGEN that provides physicians a snapshot of a limited number of factors; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.

0.89 USD

-0.03 (-3.37%)

IDXG Financial Statements

Year

2023

2022

2021

2020

Total Revenue

40.21M

31.84M

41.31M

32.4M

Cost of Revenue

16.31M

13.61M

23.37M

21.67M

Gross Profit

23.9M

18.23M

17.95M

10.72M

Operating Expenses

21.1M

22.07M

29.68M

37.28M

Research and Development

636k

703k

1.88M

2.79M

Selling, General & Administrative Expenses

19.6M

20.1M

23.74M

30.02M

Selling & Marketing Expenses

10.23M

9.13M

10.07M

9.25M

General & Administrative Expenses

9.36M

10.97M

13.67M

20.77M

Other Expenses

868k

1.27M

4.06M

4.46M

Operating Income

2.8M

-3.84M

-11.74M

-26.55M

Total Other Income/Expenses Net

-1.68M

-2.22M

-1.41M

-82k

Income Before Tax

1.13M

-5.84M

-15.41M

-26.15M

Income Tax

17k

29k

-667k

53k

Net Income

802k

-5.87M

-14.75M

-26.2M

Basic EPS

0.19

-1.38

-3.57

-6.5

EPS Diluted

0.18

-1.38

-3.57

-6.5

Basic Average Shares

4.32M

4.24M

4.13M

4.03M

Diluted Average Shares

4.36M

4.24M

4.13M

4.03M

EBITDA

3.84M

-2.27M

-1.33M

-20.1M

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep